You are here

Personalized NSAID Therapeutics Consortium

September 6, 2012: Dr. Timothy Hla is leading a prong of an interdisciplinary and inter-institutional research study from the Personalized NSAID Therapeutics Consortium. Dr. Hla will receive $709,800 over the course of five years to test in mouse models the role of COX-2 regulatory factors, such as the RNA binding protein HuR, in vascular function and the effects of pain killers (NSAIDs and COXibs).

Weill Cornell Medicine Pharmacology 1300 York Avenue,
Room E-409
New York, NY 10021 Phone: (212) 746-6250 Fax: (212) 746-8835